Biological
Influenza A virus subtype H1N1 clinical trials
- studies test it
- 21
- open now
- 0
- in phase 3
- 2
- first study started
- 2009
How studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2009 (16)
| Year | Studies |
|---|---|
| 2009 | 16 |
| 2010 | 3 |
| 2012 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 12
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 16
National Institute of Allergy and Infectious Diseases (NIAID) (8) · University of Rochester (2) · Adimmune Corporation (2) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Imperial College London (1) · Francis Corazza (1) · GlaxoSmithKline (1) · Chiltern Pesquisa Clinica Ltda (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses influenza A virus subtype H1N1 is read from its arms, and is right about nine times in ten.
Testing it · 21
- Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)CompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT01008813Written as adjuvanted A(H1N1)v influenza vaccine
- Cell Mediated Immunity Against RSV and Influenza in a Human Experimental ChallengeCompletedNot applicableImperial College LondonNCT02755948Written as Influenza A/California/04/2009-likw (H1N1)
- Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant WomenCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00992017Written as Influenza A (H1N1) monovalent vaccine
- Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and YouthCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00992836Written as Influenza A (H1N1) 2009 monovalent vaccine
- Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.CompletedNot applicableFrancis CorazzaNCT03111589Written as Inactivated influenza A (H1N1) virus vaccine
- Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese ChildrenCompletedPhase 2GlaxoSmithKlineNCT01001169Written as GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)
- Effect of Age and Prior Immunity on Response to H1N1 Vaccines in ChildrenWithdrawnPhase 4University of RochesterNCT01097941Written as Influenza A (H1N1) 2009 Monovalent Vaccine
- Immunologic Response to Inactivated Vaccine for Novel H1N1 VirusCompletedNot applicableUniversity of RochesterNCT01023711Written as Inactivated H1N1 vaccine
- Novartis H1N1 Vaccine in Pregnant WomenCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00992719Written as Inactivated H1N1 Vaccine
- Sanofi Pasteur, TIV + H1N1, Pediatric PopulationCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00943202Written as Inactivated H1N1 Vaccine
- H1N1 Vaccine in Pregnant WomenCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00963430Written as Inactivated H1N1 Vaccine
- Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00943631Written as Inactivated H1N1 Vaccine
- CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00943488Written as Inactivated H1N1 Vaccine
- Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsCompletedPhase 3Chiltern Pesquisa Clinica LtdaNCT01031719Written as adjuvanted A(H1N1) influenza vaccine
- Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy ThaisCompletedPhase 1/2Mahidol UniversityNCT01666262Written as Vaccine A/17/CA/2009/38 (H1N1)
- Sanofi H1N1 + TIV - Adults and ElderlyCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00943878Written as Inactivated H1N1 Vaccine
- Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1WithdrawnPhase 2Instituto Nacional de Salud Publica, MexicoNCT00989274Written as Vaccine Sanofi A(H1N1) 15 ug & trivalent
- Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric PopulationCompletedNot applicableAdimmune CorporationNCT01007201Written as Influenza A (H1N1) 2009 monovalent vaccine, inactivated
- Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and EldersCompletedNot applicableAdimmune CorporationNCT01003145Written as Influenza A (H1N1) 2009 monovalent vaccine, inactivated
- A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) VaccineCompletedPhase 3Green Cross CorporationNCT01201902Written as Adjuvanted influenza A(H1N1) vaccine
See all 21 studies that test influenza A virus subtype H1N1 →
Given in every arm · 2 — influenza A virus subtype H1N1 is usual care beside what is tested
- Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNot yet recruitingPhase 2Traws Pharma, Inc.NCT07503405Written as Influenza A/France/759/2021 (H1N1) virus
- CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly PopulationsWithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00964951Written as Inactivated H1N1 Vaccine
Codes
What other systems call influenza A virus subtype H1N1 · ClinicalTrials.gg INT015776
- Wikidata Q161393influenza A virus subtype H1N1One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q161393 | influenza A virus subtype H1N1 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.